Travaux scientifiques

Prof. Dr. Erdinç Nayır

72 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000610 PMID 42267536 Source : OpenAlex

  2. Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041657 PMID 41753346 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1756315 PMID 42482752 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  4. The psychosocial status of children who have a parent with cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12083 Texte intégral en libre accèsSource : OpenAlex

  5. The Silent Impact of Parental Cancer on Children’s Psychosocial Well-Being

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10467108/v1 Texte intégral en libre accèsSource : OpenAlex

  6. Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-19899-3 PMID 41102268 Texte intégral en libre accèsSource : OpenAlex

  7. Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14051742 PMID 40095849 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  9. Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study

    Neoplasma, 2023

    DOI 10.4149/neo_2022_221004n984 PMID 36620878 Texte intégral en libre accèsSource : OpenAlex

  10. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group ( TOG ) study

    Cancer Medicine, 2023

    DOI 10.1002/cam4.6869 PMID 38140782 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  11. Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1538 Texte intégral en libre accèsSource : OpenAlex

  12. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  13. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

    Anti-Cancer Drugs, 2022

    DOI 10.1097/cad.0000000000001310 PMID 35703239 3 citations (Europe PMC) Source : OpenAlex

  14. Gastrointestinal Sistem Kanserlerinde Güncel Yaklaşımlar Yazarlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.984 Texte intégral en libre accèsSource : OpenAlex

  15. Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma

    Clinical Laboratory, 2022

    DOI 10.7754/clin.lab.2021.210431 PMID 35142203 4 citations (Europe PMC) Source : ORCID

  16. Gastrointestinal Sistem Tümörleri-2

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1212 Texte intégral en libre accèsSource : OpenAlex

  17. PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

    AYBU AVESIS, 2020

    Source : OpenAlex

  18. Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    European Journal of Cancer Care, 2020

    DOI 10.1111/ecc.13296 PMID 32864838 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).

    PubMed, 2019

    PMID 30941962 4 citations (Europe PMC) Source : OpenAlex

  20. A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG)

    Van Yüzüncü Yıl University Academic Data Management System, 2019

    Source : OpenAlex

  21. Potential Effects of EGFR Exon 21 L858R Mutations in Lung Cancer

    Medical Science and Discovery, 2019

    DOI 10.17546/msd.493329 Texte intégral en libre accèsSource : OpenAlex

  22. Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group.

    PubMed, 2019

    PMID 31128019 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  23. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study

    Archives of Medical Science, 2019

    DOI 10.5114/aoms.2019.83000 PMID 34336021 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  24. The Effects of EGFR Exon 19 747–750 Deletion on the Risk of Developing Lung Cancer

    Medical Science and Discovery, 2019

    DOI 10.17546/msd.569279 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  25. Comparison of combined chemoradiotherapy regimens; Paclitaxel plus carboplatin and cisplatin plus etoposide for locally advanced non-small cell lung cancer: A randomised phase III trial

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz436.005 Texte intégral en libre accèsSource : OpenAlex

  26. WHICH HEMATOLOGIC PARAMETERS PREDICT SURVIVAL IN PATIENTS WITH SMALL CELL LUNG CANCER

    2019

    Source : OpenAlex

  27. Küçük Hücreli Akciğer Kanseri Hastalarinda Hangi Hematolojik Parametreler Yaşam Süresinin Belirteçleridir?

    Muğla Sıtkı Koçman University Institutional Repository, 2019

    Texte intégral en libre accèsSource : OpenAlex

  28. Primer Karaciğer Tümörlerinde Onkolojik Tedavi

    Turkiye Klinikleri General Surgery - Special Topics, 2018

    Source : OpenAlex

  29. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    Journal of Cancer Education, 2018

    DOI 10.1007/s13187-018-1441-6 PMID 30446981 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  30. Is there an association between CRP levels and tumor size in breast cancer patients?

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2017.08.004 Texte intégral en libre accèsSource : OpenAlex

  31. Gebelik ve Meme Kanseri (TOG Meme ve Genç Araştırmacılar Grubu çalışması)

    Kocaeli Üniversitesi - AVESİS, 2018

    Source : OpenAlex

  32. kras wild tip metastatik kolorektal kanser Birinci sıra tedavide Bevasizumab,setuksimab ve panitumumab içeren rejimlerin etkinlik ve yan etki profilinin retrospektif değerlendiirlmesi(türk onkoloji grubuna ait option çalışmasının ilk sonuçları)

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Source : OpenAlex

  33. Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture

    Journal of Oncological Sciences, 2017

    DOI 10.1016/j.jons.2017.05.005 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  34. Efficacy of Metronomic Vinorelbine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer and Poor Performance Status

    Current Oncology, 2017

    DOI 10.3747/co.24.3486 PMID 28680287 21 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  35. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

    Cancer Investigation, 2017

    DOI 10.1080/07357907.2017.1292518 PMID 28333566 6 citations (Europe PMC) Source : OpenAlex

  36. Oncologists’ Perspectives on Consolidation Radiation Treatment after Chemotherapy for Lymphomas: A Survey Study by the Lymphoma Working Committee of the Turkish Oncology Group (TOG)

    Europe PMC (PubMed Central), 2017

    DOI 10.22034/apjcp.2017.18.11.3149 PMID 29172293 Texte intégral en libre accèsSource : OpenAlex

  37. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e19027 Source : ORCID

  38. Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study

    Journal of B.U.ON., 2017

    PMID 28365956 2 citations (OpenAlex) Source : ORCID

  39. What is the future in the treatment of triple-negative breast cancer?

    Journal of Oncological Sciences, 2017

    DOI 10.1016/j.jons.2017.08.001 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. PERSPECTIVES OF TURKISH MEDICAL SCHOOL STUDENTS ON CANCER, CANCER TREATMENTS, PALLIATIVE CARE, AND THE ONCOLOGISTS: ARES STUDY.

    Çanakkale Onsekiz Mart University AVESIS, 2017

    Source : OpenAlex

  41. Clinical and pathological evaluation of histopathological subtypes in patients with non-Hodgkin’s lymphoma

    The European Research Journal, 2016

    DOI 10.18621/eurj.2016.2.1.52 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  42. A snapshot of residents in medical oncology in Turkey: A Nationwide survey on profile and key problems

    Journal of Oncological Sciences, 2016

    DOI 10.1016/j.jons.2016.05.001 Texte intégral en libre accèsSource : OpenAlex

  43. Bilateral breast cancer and stomach metastasis: A Case Report

    Acta Oncologica Turcica, 2016

    DOI 10.5505/aot.2016.74046 Texte intégral en libre accèsSource : OpenAlex

  44. Alteration of thyroid functions in patients with renal cell carcinoma treated with tyrosine kinase inhibitors; Turkish population study.

    DergiPark (Istanbul University), 2016

    Source : OpenAlex

  45. Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) Study.

    PubMed, 2016

    PMID 27569068 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  46. Do we initiate chemotherapy at an early stage of hormone-sensitive metastatic prostate cancer?

    Turk Onkoloji Dergisi, 2016

    DOI 10.5505/tjo.2016.1478 Texte intégral en libre accèsSource : ORCID

  47. Ganoderma Lucidum (Reishi Mushroom) and cancer

    Journal of B.U.ON., 2016

    PMID 27685898 45 citations (OpenAlex) Source : ORCID

  48. Orbital metastasis of multiple myeloma: Case report

    Turk Oftalmoloiji Dergisi, 2016

    DOI 10.4274/tjo.73645 PMID 27800278 9 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  49. TS 1494del6 polymorphism and increased risk of developing breast cancer

    International Journal of Clinical and Experimental Medicine, 2016

    Source : ORCID

  50. Curcumin (Turmeric) and cancer

    Journal of B.U.ON., 2016

    Source : ORCID